Janus Henderson Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Hold |
15,031
| – | – | ﹤0.01% | 2346 |
|
|
2025
Q1 | $78.4K | Hold |
15,031
| – | – | ﹤0.01% | 2469 |
|
|
2024
Q4 | $84.5K | Hold |
15,031
| – | – | ﹤0.01% | 2513 |
|
|
2024
Q3 | $72.7K | Hold |
15,031
| – | – | ﹤0.01% | 2525 |
|
|
2024
Q2 | $73.3K | Sell |
15,031
-256
| -2% | -$1.25K | ﹤0.01% | 2508 |
|
|
2024
Q1 | $203K | Buy |
15,287
+35
| +0.2% | +$464 | ﹤0.01% | 2414 |
|
|
2023
Q4 | $212K | Sell |
15,252
-27
| -0.2% | -$376 | ﹤0.01% | 2413 |
|
|
2023
Q3 | $202K | Buy |
15,279
+24
| +0.2% | +$318 | ﹤0.01% | 2379 |
|
|
2023
Q2 | $286K | Sell |
15,255
-31
| -0.2% | -$581 | ﹤0.01% | 2271 |
|
|
2023
Q1 | $220K | Buy |
+15,286
| New | +$220K | ﹤0.01% | 2445 |
|
|
2022
Q4 | – | Sell |
-7,268
| Closed | -$250K | – | 2507 |
|
|
2022
Q3 | $250K | Buy |
+7,268
| New | +$250K | ﹤0.01% | 2289 |
|
|
2022
Q2 | – | Sell |
-690,011
| Closed | -$15.7M | – | 2689 |
|
|
2022
Q1 | $15.7M | Sell |
690,011
-472,785
| -41% | -$10.8M | 0.01% | 796 |
|
|
2021
Q4 | $41.2M | Buy |
1,162,796
+1,913
| +0.2% | +$67.8K | 0.02% | 609 |
|
|
2021
Q3 | $52.5M | Sell |
1,160,883
-252,888
| -18% | -$11.4M | 0.02% | 536 |
|
|
2021
Q2 | $79.8M | Buy |
+1,413,771
| New | +$79.8M | 0.03% | 434 |
|